What does acquired in-process research and development mean?

This represents the portion of an acquisition purchase price allocated to research and development projects that have not yet reached technological feasibility. It reflects the company's strategy of buying innovation rather than developing it internally. Investors use this to assess the cost of inorganic growth and the potential future value of the acquired R&D pipeline.

Digi International DGII Acquired in-process research and development

Acquired in-process research and development at other companies

BeldenBDC

$30.09M+5.9%

Other financials

Income statement

See full

Revenue$130.7M+25.1%

Gross profit$83.7M+28.9%

Operating income$17.1M+24.4%

Net income$11.3M+7.7%

EPS (diluted)$0.29+3.6%

Balance sheet

See full

Cash & equivalents$31.7M+20.7%

Total debt$153.9M+85.5%

Total equity$666.0M+10.0%

Total assets$974.2M+24.7%

Cash flow

See full

Operating cash flow$41.5M+57.8%

CapEx$638.0K+14.3%

Free cash flow$40.8M+58.7%

Valuation

See full

Market cap$2.59B+76.5%

Enterprise value$2.71B+78.6%

P/E59.9×+25.1×

P/S5.5×+2.0×

Profitability

See full

Gross margin63.4%+2.3pp

Operating margin13.2%+0.1pp

Net margin9.1%-1.0pp

FCF margin26.6%+1.6pp

Returns & leverage

See full

Return on equity6.8%-0.5pp

Debt / equity0.2×+0.1×

Current ratio1.1×-0.5×

Where this comes from

Reported directly by Digi International in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfIntangibleAssets.

The official record: Digi International’s 10-Q, filed February 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Digi International's acquired in-process research and development.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Digi International's acquired in-process research and development?: Digi International (DGII) reported acquired in-process research and development of $300K in Q4 2025.
What does acquired in-process research and development mean?: This represents the portion of an acquisition purchase price allocated to research and development projects that have not yet reached technological feasibility. It reflects the company's strategy of buying innovation rather than developing it internally. Investors use this to assess the cost of inorganic growth and the potential future value of the acquired R&D pipeline.